Laurent Gapin
Concepts (335)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Killer T-Cells | 24 | 2022 | 63 | 7.180 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 34 | 2021 | 309 | 4.980 |
Why?
| Thymus Gland | 19 | 2020 | 296 | 3.550 |
Why?
| T-Lymphocyte Subsets | 17 | 2024 | 383 | 3.340 |
Why?
| Killer Cells, Natural | 23 | 2018 | 380 | 2.920 |
Why?
| Antigens, CD1d | 23 | 2020 | 63 | 2.650 |
Why?
| Antigens, CD1 | 14 | 2021 | 57 | 2.590 |
Why?
| Cell Differentiation | 14 | 2020 | 1700 | 2.410 |
Why?
| T-Lymphocytes | 20 | 2021 | 1736 | 2.340 |
Why?
| Receptors, Antigen, T-Cell | 15 | 2024 | 615 | 2.150 |
Why?
| Histocompatibility Antigens Class I | 7 | 2016 | 172 | 1.350 |
Why?
| Thymocytes | 5 | 2020 | 28 | 1.160 |
Why?
| T-Cell Antigen Receptor Specificity | 6 | 2017 | 41 | 1.130 |
Why?
| Mucosal-Associated Invariant T Cells | 2 | 2022 | 16 | 1.010 |
Why?
| Histocompatibility Antigens Class II | 10 | 2020 | 352 | 0.960 |
Why?
| Antigen Presentation | 9 | 2018 | 188 | 0.950 |
Why?
| Animals | 77 | 2022 | 31694 | 0.950 |
Why?
| Histocompatibility Antigens | 4 | 2019 | 98 | 0.950 |
Why?
| Mice | 63 | 2022 | 14860 | 0.940 |
Why?
| Glycolipids | 5 | 2018 | 35 | 0.920 |
Why?
| Autoantigens | 6 | 2020 | 396 | 0.910 |
Why?
| Mice, Inbred C57BL | 30 | 2020 | 4689 | 0.890 |
Why?
| Evolution, Molecular | 3 | 2019 | 430 | 0.860 |
Why?
| Immunity, Innate | 3 | 2020 | 720 | 0.750 |
Why?
| Single-Cell Analysis | 2 | 2021 | 188 | 0.680 |
Why?
| Galactosylceramides | 10 | 2012 | 22 | 0.670 |
Why?
| Minor Histocompatibility Antigens | 3 | 2016 | 41 | 0.670 |
Why?
| Lymphocyte Activation | 17 | 2020 | 1037 | 0.630 |
Why?
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 6 | 2012 | 21 | 0.620 |
Why?
| Flow Cytometry | 6 | 2018 | 1083 | 0.610 |
Why?
| Models, Immunological | 3 | 2007 | 92 | 0.590 |
Why?
| Mice, Knockout | 16 | 2020 | 2565 | 0.570 |
Why?
| Demethylation | 1 | 2017 | 3 | 0.570 |
Why?
| Genes, MHC Class I | 1 | 2016 | 32 | 0.530 |
Why?
| Mice, Inbred BALB C | 11 | 2019 | 1143 | 0.530 |
Why?
| Wasp Venoms | 1 | 2016 | 4 | 0.530 |
Why?
| Bee Venoms | 1 | 2016 | 8 | 0.520 |
Why?
| CD4-Positive T-Lymphocytes | 8 | 2021 | 959 | 0.520 |
Why?
| Autoimmunity | 8 | 2020 | 813 | 0.510 |
Why?
| Immunity, Mucosal | 2 | 2014 | 84 | 0.510 |
Why?
| Intestinal Mucosa | 3 | 2014 | 532 | 0.510 |
Why?
| T-Box Domain Proteins | 6 | 2007 | 92 | 0.490 |
Why?
| Cells, Cultured | 11 | 2020 | 3881 | 0.490 |
Why?
| CD8-Positive T-Lymphocytes | 9 | 2013 | 687 | 0.450 |
Why?
| Pterins | 1 | 2012 | 8 | 0.420 |
Why?
| Immunologic Memory | 7 | 2020 | 313 | 0.420 |
Why?
| Major Histocompatibility Complex | 5 | 2017 | 217 | 0.420 |
Why?
| Antigens | 8 | 2020 | 318 | 0.410 |
Why?
| Peptide Fragments | 7 | 2019 | 665 | 0.410 |
Why?
| Hypersensitivity | 1 | 2016 | 252 | 0.400 |
Why?
| Protein Conformation | 7 | 2018 | 805 | 0.400 |
Why?
| Mice, Transgenic | 10 | 2018 | 1947 | 0.390 |
Why?
| Folic Acid | 1 | 2012 | 161 | 0.380 |
Why?
| Globosides | 2 | 2011 | 2 | 0.380 |
Why?
| Self Tolerance | 1 | 2010 | 28 | 0.350 |
Why?
| Dendritic Cells | 6 | 2013 | 435 | 0.340 |
Why?
| Signal Transduction | 5 | 2020 | 4509 | 0.340 |
Why?
| Transcription Factors | 6 | 2016 | 1528 | 0.340 |
Why?
| Interferon-gamma | 8 | 2020 | 719 | 0.330 |
Why?
| Escherichia coli | 1 | 2013 | 720 | 0.320 |
Why?
| CD8 Antigens | 3 | 2013 | 69 | 0.320 |
Why?
| Th1 Cells | 2 | 2007 | 123 | 0.320 |
Why?
| Lipids | 5 | 2021 | 580 | 0.310 |
Why?
| Immune Tolerance | 3 | 2020 | 323 | 0.310 |
Why?
| Muramidase | 4 | 2002 | 72 | 0.310 |
Why?
| Protein Binding | 9 | 2019 | 1889 | 0.300 |
Why?
| Lymphocyte Subsets | 2 | 2005 | 79 | 0.300 |
Why?
| Cell Line | 7 | 2020 | 2635 | 0.290 |
Why?
| Galactosyltransferases | 1 | 2007 | 11 | 0.290 |
Why?
| Hybridomas | 6 | 2019 | 230 | 0.280 |
Why?
| Humans | 34 | 2024 | 114623 | 0.270 |
Why?
| Early Growth Response Protein 2 | 2 | 2018 | 10 | 0.270 |
Why?
| Antigens, Bacterial | 3 | 2017 | 112 | 0.260 |
Why?
| Genes, T-Cell Receptor alpha | 2 | 2003 | 11 | 0.260 |
Why?
| Cell Movement | 2 | 2007 | 868 | 0.260 |
Why?
| Gene Expression Profiling | 3 | 2020 | 1518 | 0.250 |
Why?
| Peptides | 5 | 2016 | 848 | 0.240 |
Why?
| Crystallography, X-Ray | 3 | 2018 | 402 | 0.240 |
Why?
| Immunoglobulin Variable Region | 4 | 2012 | 72 | 0.240 |
Why?
| Models, Molecular | 8 | 2013 | 1369 | 0.230 |
Why?
| Immunophenotyping | 4 | 2018 | 274 | 0.230 |
Why?
| Gene Expression Regulation | 4 | 2013 | 2319 | 0.230 |
Why?
| CD40 Antigens | 4 | 2014 | 82 | 0.220 |
Why?
| Mutation | 5 | 2019 | 3344 | 0.210 |
Why?
| Amino Acid Sequence | 8 | 2019 | 1982 | 0.200 |
Why?
| Surface Plasmon Resonance | 5 | 2013 | 81 | 0.200 |
Why?
| Hematologic Neoplasms | 1 | 2024 | 137 | 0.200 |
Why?
| Interleukin-4 | 4 | 2003 | 206 | 0.190 |
Why?
| Strongylida Infections | 1 | 2021 | 6 | 0.190 |
Why?
| Syk Kinase | 1 | 2020 | 18 | 0.180 |
Why?
| Retroviridae | 2 | 2013 | 90 | 0.180 |
Why?
| H-2 Antigens | 1 | 1999 | 110 | 0.170 |
Why?
| Binding Sites | 3 | 2018 | 1168 | 0.160 |
Why?
| Amino Acid Motifs | 1 | 2019 | 197 | 0.160 |
Why?
| Immunity, Cellular | 1 | 2020 | 248 | 0.160 |
Why?
| Respiratory Hypersensitivity | 2 | 2010 | 60 | 0.160 |
Why?
| Immune System | 2 | 2013 | 172 | 0.150 |
Why?
| Sequence Analysis, RNA | 1 | 2020 | 385 | 0.150 |
Why?
| Cell Line, Transformed | 1 | 2018 | 133 | 0.150 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2020 | 191 | 0.150 |
Why?
| Immunodominant Epitopes | 1 | 1998 | 25 | 0.150 |
Why?
| NFATC Transcription Factors | 1 | 2018 | 78 | 0.150 |
Why?
| Complementarity Determining Regions | 5 | 2012 | 43 | 0.150 |
Why?
| Mycolic Acids | 1 | 2017 | 6 | 0.150 |
Why?
| Selection, Genetic | 1 | 2019 | 242 | 0.150 |
Why?
| Mutagenesis | 3 | 2013 | 168 | 0.140 |
Why?
| Cell Wall | 1 | 2017 | 52 | 0.140 |
Why?
| Viral Vaccines | 1 | 1998 | 88 | 0.140 |
Why?
| Histone Demethylases | 1 | 2017 | 28 | 0.140 |
Why?
| Skin | 1 | 2021 | 655 | 0.140 |
Why?
| Interleukin-15 | 3 | 2013 | 74 | 0.140 |
Why?
| Protein Isoforms | 1 | 2018 | 338 | 0.140 |
Why?
| Staphylococcal Infections | 1 | 2020 | 336 | 0.140 |
Why?
| Transcription Activator-Like Effector Nucleases | 1 | 2016 | 5 | 0.130 |
Why?
| Cell Lineage | 2 | 2013 | 309 | 0.130 |
Why?
| Ovalbumin | 3 | 2014 | 161 | 0.130 |
Why?
| Insulin | 2 | 2019 | 2076 | 0.130 |
Why?
| Lymph Nodes | 2 | 2021 | 419 | 0.130 |
Why?
| Alleles | 2 | 2017 | 789 | 0.130 |
Why?
| Latent Tuberculosis | 1 | 2016 | 64 | 0.130 |
Why?
| Tissue Distribution | 1 | 2016 | 286 | 0.120 |
Why?
| Coculture Techniques | 2 | 2013 | 201 | 0.120 |
Why?
| Amino Acids | 2 | 2009 | 448 | 0.120 |
Why?
| Cytokines | 4 | 2020 | 1840 | 0.120 |
Why?
| Receptors, Natural Killer Cell | 2 | 2011 | 16 | 0.120 |
Why?
| Adoptive Transfer | 4 | 2020 | 195 | 0.120 |
Why?
| Mycobacterium tuberculosis | 1 | 2017 | 268 | 0.120 |
Why?
| Bacterial Vaccines | 1 | 2014 | 61 | 0.120 |
Why?
| DNA-Binding Proteins | 1 | 2020 | 1314 | 0.110 |
Why?
| Germ Cells | 2 | 2016 | 57 | 0.110 |
Why?
| Adaptive Immunity | 1 | 2014 | 155 | 0.110 |
Why?
| Endopeptidase K | 1 | 2013 | 14 | 0.110 |
Why?
| Interleukins | 1 | 2014 | 236 | 0.100 |
Why?
| Sulfoglycosphingolipids | 1 | 2012 | 3 | 0.100 |
Why?
| Polymerase Chain Reaction | 3 | 2012 | 993 | 0.100 |
Why?
| Proteolysis | 1 | 2013 | 142 | 0.100 |
Why?
| Epitopes | 2 | 2011 | 435 | 0.100 |
Why?
| Cell Proliferation | 5 | 2020 | 2186 | 0.100 |
Why?
| B-Lymphocytes | 2 | 2013 | 766 | 0.100 |
Why?
| Histones | 1 | 2017 | 535 | 0.100 |
Why?
| Burkitt Lymphoma | 1 | 2012 | 52 | 0.100 |
Why?
| CD40 Ligand | 1 | 2012 | 39 | 0.100 |
Why?
| Interleukin-2 Receptor beta Subunit | 2 | 2013 | 19 | 0.100 |
Why?
| Trihexosylceramides | 1 | 2011 | 4 | 0.100 |
Why?
| Promoter Regions, Genetic | 2 | 2013 | 1131 | 0.090 |
Why?
| Th2 Cells | 2 | 2003 | 154 | 0.090 |
Why?
| Immunoglobulin Joining Region | 2 | 2001 | 10 | 0.090 |
Why?
| Neoplasms | 1 | 2024 | 2097 | 0.090 |
Why?
| Molecular Sequence Data | 6 | 2011 | 2785 | 0.090 |
Why?
| CD27 Ligand | 1 | 2009 | 9 | 0.090 |
Why?
| Lipid Metabolism | 1 | 2013 | 444 | 0.090 |
Why?
| Multiprotein Complexes | 1 | 2011 | 140 | 0.080 |
Why?
| Epitopes, T-Lymphocyte | 3 | 2019 | 170 | 0.080 |
Why?
| Biomarkers | 2 | 2018 | 3408 | 0.080 |
Why?
| In Vitro Techniques | 1 | 2011 | 1016 | 0.080 |
Why?
| Mice, Inbred NOD | 3 | 2019 | 555 | 0.080 |
Why?
| Colitis | 2 | 2002 | 223 | 0.080 |
Why?
| Immunization | 3 | 2013 | 397 | 0.070 |
Why?
| Cytotoxicity, Immunologic | 1 | 2008 | 195 | 0.070 |
Why?
| Crystallography | 1 | 2007 | 25 | 0.070 |
Why?
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2007 | 11 | 0.070 |
Why?
| Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.070 |
Why?
| Receptors, Thyroid Hormone | 1 | 2007 | 20 | 0.070 |
Why?
| Receptors, Retinoic Acid | 1 | 2007 | 49 | 0.070 |
Why?
| Adjuvants, Immunologic | 2 | 2014 | 206 | 0.070 |
Why?
| Receptors, CXCR3 | 1 | 2007 | 15 | 0.070 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2007 | 97 | 0.070 |
Why?
| Receptors, Chemokine | 1 | 2007 | 44 | 0.070 |
Why?
| Estrogen Antagonists | 1 | 2007 | 39 | 0.070 |
Why?
| RNA, Messenger | 3 | 2003 | 2552 | 0.070 |
Why?
| Clone Cells | 3 | 2017 | 247 | 0.070 |
Why?
| Allergens | 1 | 2010 | 413 | 0.070 |
Why?
| Vaccination | 1 | 2014 | 1204 | 0.070 |
Why?
| Time Factors | 2 | 2013 | 6112 | 0.070 |
Why?
| Tamoxifen | 1 | 2007 | 191 | 0.070 |
Why?
| Female | 10 | 2020 | 59466 | 0.060 |
Why?
| Diabetes Mellitus, Type 1 | 2 | 2019 | 3244 | 0.060 |
Why?
| Cross Reactions | 2 | 2017 | 117 | 0.060 |
Why?
| Interleukin-12 | 2 | 2020 | 110 | 0.060 |
Why?
| T-Lymphocytes, Cytotoxic | 2 | 2012 | 154 | 0.060 |
Why?
| Transcription, Genetic | 3 | 2020 | 1313 | 0.060 |
Why?
| Receptors, Estrogen | 1 | 2007 | 372 | 0.060 |
Why?
| Inflammation | 2 | 2020 | 2477 | 0.060 |
Why?
| Cell Survival | 1 | 2005 | 1020 | 0.050 |
Why?
| Structure-Activity Relationship | 3 | 2011 | 502 | 0.050 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 367 | 0.050 |
Why?
| Nippostrongylus | 1 | 2021 | 3 | 0.050 |
Why?
| Tumor Microenvironment | 1 | 2024 | 430 | 0.050 |
Why?
| Bacterial Load | 1 | 2020 | 58 | 0.040 |
Why?
| Crystallization | 2 | 2012 | 136 | 0.040 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2020 | 90 | 0.040 |
Why?
| Receptors, Interleukin | 2 | 2014 | 39 | 0.040 |
Why?
| Colon | 1 | 2002 | 233 | 0.040 |
Why?
| Interleukin-10 | 1 | 2002 | 299 | 0.040 |
Why?
| Immunotherapy | 1 | 2024 | 474 | 0.040 |
Why?
| Histocompatibility Antigen H-2D | 1 | 1999 | 21 | 0.040 |
Why?
| Spleen | 2 | 2000 | 487 | 0.040 |
Why?
| Lymphopenia | 1 | 1999 | 49 | 0.040 |
Why?
| Cloning, Molecular | 2 | 2011 | 522 | 0.040 |
Why?
| DNA Repair | 1 | 2020 | 184 | 0.040 |
Why?
| Mice, Inbred Strains | 1 | 1999 | 396 | 0.040 |
Why?
| Molecular Docking Simulation | 1 | 2019 | 101 | 0.040 |
Why?
| Male | 4 | 2020 | 55554 | 0.040 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2012 | 2094 | 0.040 |
Why?
| Lysosomes | 1 | 2019 | 123 | 0.040 |
Why?
| Gene Rearrangement, T-Lymphocyte | 1 | 1998 | 13 | 0.040 |
Why?
| HLA-DQ Antigens | 1 | 2019 | 174 | 0.040 |
Why?
| CD3 Complex | 1 | 2018 | 92 | 0.040 |
Why?
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1998 | 25 | 0.040 |
Why?
| Antigen-Antibody Reactions | 1 | 1998 | 50 | 0.040 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 1998 | 43 | 0.040 |
Why?
| Ligands | 2 | 2010 | 561 | 0.040 |
Why?
| Protein Domains | 1 | 2019 | 207 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2020 | 295 | 0.040 |
Why?
| Receptors, IgG | 1 | 1998 | 67 | 0.040 |
Why?
| Cell Cycle | 1 | 2020 | 542 | 0.040 |
Why?
| Chickens | 1 | 1998 | 177 | 0.040 |
Why?
| Immunologic Techniques | 1 | 2017 | 39 | 0.040 |
Why?
| Phenotype | 2 | 2020 | 2796 | 0.040 |
Why?
| Stem Cells | 1 | 2001 | 545 | 0.040 |
Why?
| Mice, Mutant Strains | 2 | 2007 | 271 | 0.030 |
Why?
| Mycobacterium phlei | 1 | 2016 | 1 | 0.030 |
Why?
| Rhodococcus equi | 1 | 2016 | 1 | 0.030 |
Why?
| Substrate Specificity | 1 | 2017 | 352 | 0.030 |
Why?
| Pancreas | 1 | 2019 | 276 | 0.030 |
Why?
| Mice, SCID | 2 | 2012 | 314 | 0.030 |
Why?
| Bone Marrow Cells | 2 | 2010 | 267 | 0.030 |
Why?
| Aging | 2 | 2002 | 1618 | 0.030 |
Why?
| Transcriptome | 1 | 2020 | 725 | 0.030 |
Why?
| Radiation Chimera | 1 | 2014 | 30 | 0.030 |
Why?
| Vaccinia | 1 | 2014 | 18 | 0.030 |
Why?
| Smallpox Vaccine | 1 | 2014 | 22 | 0.030 |
Why?
| Receptors, Cytokine | 1 | 2014 | 33 | 0.030 |
Why?
| STAT Transcription Factors | 1 | 2014 | 13 | 0.030 |
Why?
| Poly I-C | 1 | 2014 | 51 | 0.030 |
Why?
| Lectins, C-Type | 2 | 2007 | 61 | 0.030 |
Why?
| Disease Models, Animal | 2 | 2020 | 3531 | 0.030 |
Why?
| Vaccines, Subunit | 1 | 2014 | 41 | 0.030 |
Why?
| Listeriosis | 1 | 2014 | 61 | 0.030 |
Why?
| Base Sequence | 1 | 1998 | 2114 | 0.030 |
Why?
| Alanine | 2 | 2008 | 104 | 0.030 |
Why?
| Toll-Like Receptors | 1 | 2014 | 167 | 0.030 |
Why?
| Case-Control Studies | 1 | 2020 | 3003 | 0.030 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2016 | 339 | 0.030 |
Why?
| Clinical Trials as Topic | 1 | 1998 | 931 | 0.030 |
Why?
| Transplantation Chimera | 1 | 2013 | 51 | 0.030 |
Why?
| Whole-Body Irradiation | 1 | 2013 | 73 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2019 | 2710 | 0.030 |
Why?
| Protein Structure, Quaternary | 1 | 2012 | 115 | 0.030 |
Why?
| Vaccines, Synthetic | 1 | 2012 | 124 | 0.030 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2012 | 59 | 0.020 |
Why?
| Oligopeptides | 1 | 1993 | 236 | 0.020 |
Why?
| Neoplasm Transplantation | 1 | 2012 | 228 | 0.020 |
Why?
| Transduction, Genetic | 1 | 2012 | 113 | 0.020 |
Why?
| Tumor Burden | 1 | 2012 | 259 | 0.020 |
Why?
| Molecular Mimicry | 1 | 2011 | 35 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 923 | 0.020 |
Why?
| Carbohydrate Sequence | 1 | 2011 | 23 | 0.020 |
Why?
| Germ-Line Mutation | 1 | 2012 | 130 | 0.020 |
Why?
| Antigens, Neoplasm | 1 | 2012 | 221 | 0.020 |
Why?
| Protein Engineering | 1 | 2011 | 98 | 0.020 |
Why?
| Thermodynamics | 2 | 2008 | 382 | 0.020 |
Why?
| Microscopy, Fluorescence | 1 | 2012 | 396 | 0.020 |
Why?
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2009 | 5 | 0.020 |
Why?
| Bronchial Hyperreactivity | 1 | 2010 | 95 | 0.020 |
Why?
| Adaptation, Biological | 1 | 2009 | 53 | 0.020 |
Why?
| Graft Rejection | 1 | 2012 | 513 | 0.020 |
Why?
| Chimera | 1 | 2009 | 59 | 0.020 |
Why?
| Lung | 1 | 2021 | 3558 | 0.020 |
Why?
| Listeria monocytogenes | 1 | 2009 | 111 | 0.020 |
Why?
| Precursor Cells, T-Lymphoid | 1 | 2008 | 1 | 0.020 |
Why?
| Intubation, Intratracheal | 1 | 2010 | 216 | 0.020 |
Why?
| Kinetics | 1 | 2011 | 1551 | 0.020 |
Why?
| Gene Expression | 1 | 2013 | 1421 | 0.020 |
Why?
| Bone Marrow | 1 | 2009 | 243 | 0.020 |
Why?
| Receptors, Interleukin-7 | 1 | 2007 | 25 | 0.020 |
Why?
| Sequence Alignment | 1 | 2008 | 323 | 0.020 |
Why?
| Models, Biological | 1 | 1994 | 1620 | 0.020 |
Why?
| Amino Acid Substitution | 1 | 2008 | 262 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2010 | 477 | 0.020 |
Why?
| Protein Structure, Secondary | 1 | 2008 | 325 | 0.020 |
Why?
| Species Specificity | 1 | 2008 | 542 | 0.020 |
Why?
| Receptors, Immunologic | 1 | 2007 | 201 | 0.020 |
Why?
| Receptors, Interleukin-2 | 1 | 2005 | 64 | 0.020 |
Why?
| Amidohydrolases | 1 | 2004 | 28 | 0.010 |
Why?
| GPI-Linked Proteins | 1 | 2004 | 54 | 0.010 |
Why?
| Precipitin Tests | 1 | 2004 | 88 | 0.010 |
Why?
| CpG Islands | 1 | 2004 | 117 | 0.010 |
Why?
| Receptors, Interleukin-12 | 1 | 2003 | 6 | 0.010 |
Why?
| Cell Adhesion Molecules | 1 | 2004 | 168 | 0.010 |
Why?
| Crosses, Genetic | 1 | 2003 | 139 | 0.010 |
Why?
| Fluorescence | 1 | 2003 | 148 | 0.010 |
Why?
| Organ Culture Techniques | 1 | 2003 | 140 | 0.010 |
Why?
| Stromal Cells | 1 | 2003 | 96 | 0.010 |
Why?
| Aged | 1 | 2020 | 19061 | 0.010 |
Why?
| Liver | 1 | 2010 | 1634 | 0.010 |
Why?
| Cloning, Organism | 1 | 2002 | 6 | 0.010 |
Why?
| Phosphoproteins | 1 | 2004 | 298 | 0.010 |
Why?
| Freund's Adjuvant | 1 | 2002 | 17 | 0.010 |
Why?
| Aluminum Hydroxide | 1 | 2002 | 12 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 740 | 0.010 |
Why?
| Hematopoietic Stem Cells | 1 | 2004 | 343 | 0.010 |
Why?
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2000 | 10 | 0.010 |
Why?
| Middle Aged | 1 | 2020 | 26719 | 0.010 |
Why?
| Antigens, Ly | 1 | 2000 | 45 | 0.010 |
Why?
| Homeostasis | 1 | 2004 | 573 | 0.010 |
Why?
| Carrier Proteins | 1 | 2004 | 695 | 0.010 |
Why?
| Antigens, Surface | 1 | 2000 | 146 | 0.010 |
Why?
| Intestine, Large | 1 | 2000 | 13 | 0.010 |
Why?
| Genes, T-Cell Receptor beta | 1 | 2000 | 18 | 0.010 |
Why?
| Dimerization | 1 | 2000 | 176 | 0.010 |
Why?
| Chromatin | 1 | 2003 | 428 | 0.010 |
Why?
| Leukocyte Common Antigens | 1 | 2000 | 75 | 0.010 |
Why?
| Clonal Anergy | 1 | 2000 | 53 | 0.010 |
Why?
| CD4 Antigens | 1 | 2000 | 123 | 0.010 |
Why?
| Lymphocyte Depletion | 1 | 2000 | 116 | 0.010 |
Why?
| Animals, Newborn | 1 | 2002 | 778 | 0.010 |
Why?
| Adult | 1 | 2020 | 30528 | 0.010 |
Why?
| Membrane Proteins | 1 | 2004 | 1018 | 0.010 |
Why?
| Leucine | 1 | 1998 | 102 | 0.010 |
Why?
| Epithelial Cells | 1 | 2003 | 950 | 0.010 |
Why?
| Point Mutation | 1 | 1998 | 216 | 0.010 |
Why?
| Vaccines | 1 | 2002 | 375 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 1998 | 849 | 0.010 |
Why?
| Antigens, CD | 1 | 1998 | 442 | 0.010 |
Why?
| Proteins | 1 | 2000 | 908 | 0.010 |
Why?
| Endopeptidases | 1 | 1994 | 71 | 0.010 |
Why?
| Binding, Competitive | 1 | 1994 | 193 | 0.010 |
Why?
| Dansyl Compounds | 1 | 1993 | 4 | 0.010 |
Why?
| Organelles | 1 | 1994 | 51 | 0.010 |
Why?
| Plasmodium berghei | 1 | 1993 | 7 | 0.010 |
Why?
| Endocytosis | 1 | 1994 | 148 | 0.010 |
Why?
| Macromolecular Substances | 1 | 1993 | 200 | 0.010 |
Why?
| Hydrogen-Ion Concentration | 1 | 1993 | 511 | 0.010 |
Why?
| Recombinant Proteins | 1 | 1993 | 1230 | 0.010 |
Why?
|
|
Gapin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|